189 related articles for article (PubMed ID: 34235792)
1. Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: A systematic review and meta-analysis.
Kaçmaz E; Chen JW; Tanis PJ; Nieveen van Dijkum EJM; Engelsman AF
J Neuroendocrinol; 2021 Aug; 33(8):e13008. PubMed ID: 34235792
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node metastases.
Kaçmaz E; Slooter MD; Nieveen van Dijkum EJM; Tanis PJ; Engelsman AF
Eur J Surg Oncol; 2021 Jul; 47(7):1611-1615. PubMed ID: 33353827
[TBL] [Abstract][Full Text] [Related]
4. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
[TBL] [Abstract][Full Text] [Related]
5. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
6. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
Pommergaard HC; Nielsen K; Sorbye H; Federspiel B; Tabaksblat EM; Vestermark LW; Janson ET; Hansen CP; Ladekarl M; Garresori H; Hjortland GO; Sundlöv A; Galleberg R; Knigge P; Kjaer A; Langer SW; Knigge U
J Neuroendocrinol; 2021 May; 33(5):e12967. PubMed ID: 33769624
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand.
McGuinness MJ; Woodhouse B; Harmston C; Parker K; Kramer N; Findlay M; Print C; Merrie A; Lawrence B
ANZ J Surg; 2022 Jul; 92(7-8):1748-1753. PubMed ID: 35762209
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
[TBL] [Abstract][Full Text] [Related]
9. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Farley HA; Pommier RF
Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
[TBL] [Abstract][Full Text] [Related]
10. Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.
Ethun CG; Postlewait LM; Baptiste GG; McInnis MR; Cardona K; Russell MC; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Nov; 114(6):671-676. PubMed ID: 27511436
[TBL] [Abstract][Full Text] [Related]
11. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
13. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
Gangi A; Anaya DA
Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.
Jilesen AP; van Eijck CH; in't Hof KH; van Dieren S; Gouma DJ; van Dijkum EJ
World J Surg; 2016 Mar; 40(3):729-48. PubMed ID: 26661846
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
17. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
